Cargando…
COVID-19 vaccine safety surveillance and emerging concerns of vaccine-induced immune thrombotic thrombocytopenia
Autor principal: | Teo, Shyh Poh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Science Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648542/ https://www.ncbi.nlm.nih.gov/pubmed/34908929 http://dx.doi.org/10.11909/j.issn.1671-5411.2021.11.006 |
Ejemplares similares
-
Platelet count as an important prognostic factor for vaccine-induced immune thrombotic thrombocytopenia
por: Bang, Soo-Mee, et al.
Publicado: (2021) -
Understanding vaccine‐induced thrombotic thrombocytopenia (VITT)
por: Dix, Caroline, et al.
Publicado: (2022) -
Vaccine-induced immune thrombotic thrombocytopenia
por: Klok, Frederikus A, et al.
Publicado: (2022) -
Vaccine-induced immune thrombotic thrombocytopenia
por: Kanack, Adam J., et al.
Publicado: (2022) -
Vaccine-induced immune thrombotic thrombocytopenia
por: Cines, Douglas B., et al.
Publicado: (2023)